Antiretroviral treatment for HIV infection: Swedish recommendations 2019-Reference-Cited by-同舟云学术

Antiretroviral treatment for HIV infection: Swedish recommendations 2019

Published:2020-01-11 Issue:5 Volume:52 Page:295-329
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Eriksen Jaran¹²^ORCID,Carlander Christina³⁴,Albert Jan⁵⁶,Flamholc Leo⁷,Gisslén Magnus⁸⁹,Navér Lars¹⁰¹¹,Svedhem Veronica⁴¹²,Yilmaz Aylin⁸,Sönnerborg Anders⁴⁶¹²¹³

Affiliation:

1. Unit of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm, Sweden;

2. Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;

3. Department of Infectious Diseases, Västmanland County Hospital, Västerås, Sweden;

4. Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden;

5. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden;

6. Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden;

7. Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden;

8. Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;

9. Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden;

10. Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden;

11. Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden;

12. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden;

13. Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2019.1707867

Reference148 articles.

1. Antiretroviral treatment for HIV infection: Swedish recommendations 2016

2. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

3. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

4. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial

5. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024;Infectious Diseases;2024-05-28

2. Pill Burden: A Major Barrier to HAART Adherence and Fixed Dose Combinations (FDCS) as its Solution – A Mini-Review;Current HIV Research;2024-05

3. The effectiveness of treatment depending on an adherence to dispensary observation and antiretroviral therapy in patients with HIV infection;HIV Infection and Immunosuppressive Disorders;2024-04-17

4. Diagnostics of HIV-infection in the Chechen Republic: current state and prospects;Profilakticheskaya meditsina;2024

5. The consensus guideline of perioperative antiviral therapy for AIDS patients in China based on clinical practice;Frontiers in Medicine;2023-12-06